June 13, 2021 01:04 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Covid19: Maharashtra CM Uddhav Thackeray meets Sarpanches | US FDA denies India’s Covaxin emergency use approval; seeks additional clinical trial data | Mamata welcomes back Mukul Roy to TMC, shuts door for pre-poll turncoats | Sedition case against filmmaker Aisha Sultana for calling Lakshadweep administrator Praful Patel 'bio-weapon' | Yogi Adityanath meets PM Modi amid speculations over change in UP face
Dhaka inks non-disclosure vaccine deal with Beijing Dhaka
Image credit: Pixabay

Dhaka inks non-disclosure vaccine deal with Beijing

South Asia Monitor/IBNS | @indiablooms | 18 May 2021, 06:36 pm

Bangladesh has signed a non-disclosure agreement with China on purchasing Sinopharm Covid-19 vaccine and producing it in Bangladesh, a senior minister said. The agreement was sent to the Bangladesh government two to three days ago.

"We have signed the non-disclosure agreement today [Monday] and sent it to the authorities concerned," Bangladesh Health Minister Zahid Maleque told The Daily Star.

He expressed optimism that Sinopharm vaccine doses would reach the country by early next month if everything went smoothly.

The minister said the negotiation was going on very smoothly and hoped the agreement would be completed shortly.

Bangladesh last month signed a similar agreement with Russia for the production of Sputnik V vaccine.

Zahid said during discussions they proposed buying two to three crore (20 to 30 million) vaccine doses from China.

Bangladesh has already received 500,000 shots of the Sinopharm vaccine from China as a gift. It is likely to be administered to people from May 25.

On April 29, the government approved the Sinopharm vaccine for emergency use.

On the same day, the government gave in-principle approval for  local co-production of the vaccine involving Bangladeshi drug makers.

Early last year, Beijing Institute of Biological Products developed an inactivated coronavirus vaccine called BBIBP-CorV. On December 30 last year, China's state-owned company Sinopharm announced that the vaccine has an efficacy rate of 79.34 percent. The Chinese government then approved it.

China, the UAE, Bahrain, Egypt, Pakistan and some other countries are currently using it, the report said.

The vaccine has already been given to millions of people in China and elsewhere in the world. It is administered in two doses 28 days apart.


On May 7 this year, World Health Organisation granted emergency approval to the Sinopharm vaccine, the first one developed by a non-Western country to have got WHO backing.